Clinical Trial Modernization Act aims to enhance clinical trial participation and accessibility for underrepresented populations.
The Clinical Trial Modernization Act seeks to modernize clinical trials by removing barriers for participation and improving accessibility. It authorizes grants and contracts to support community education, outreach, and recruitment activities for clinical trials, particularly targeting underrepresented populations. The Act also allows for the payment of study participant clinical trial expenses and the provision of digital health technologies to facilitate participation.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.